Multiple Myeloma
Multiple Myeloma
Advertisement
Salomon Manier, MD, PhDConferences | July 10, 2024
An expert shares his insights on the challenges and practical considerations that come with bispecific antibody treatment.
View More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | June 26, 2024
Currently, there is no standardization of melphalan administration.
Cecilia BrownConferences | June 14, 2024
A real-world study presented at the EHA 2024 Congress provided insights on patient and caregiver experiences.
Katie KoskoMultiple Myeloma | June 11, 2024
The risk of hospitalization was associated with the number of drugs in a patient's myeloma treatment regimen.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | June 10, 2024
With 3 FDA-approved BiTEs for myeloma, oncology nurses must be able to understand BiTEs and explain them to patients.
Cecilia BrownMultiple Myeloma | May 23, 2024
Talquetamab is a T-cell redirecting bispecific antibody targeting GPRC5D on myeloma cells.
Cecilia BrownMultiple Myeloma | May 22, 2024
Due to the unique challenges associated with administering these therapies, a team aimed to standardize the workflow.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | May 16, 2024
Misinformation or fake news can mislead patients with multiple myeloma.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | May 14, 2024
Nurse researchers noted patients had “feelings of confusion at the time of initial diagnosis" of multiple myeloma.
Cecilia BrownConferences | June 5, 2024
The study showed that nursing support was a “key environmental facilitator" for physical activity in these patients.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 19, 2024
Although CRAB describes end-organ symptoms of multiple myeloma, it does not provide a full picture.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 8, 2024
Myeloma is a complex blood cancer that can be difficult to comprehend, especially the 2 earlier precursor disease stages.
Cecilia BrownHematology & Blood Cancer | April 8, 2024
Researchers analyzed data from more than 1 million people to determine blood cancer mortality rates from 2000-2020.
Cecilia BrownMultiple Myeloma | May 13, 2024
Age is an important prognostic factor for patients with multiple myeloma.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | April 4, 2024
Learn how to ask informed questions, connect patients with resources, and support shared-decision making.
Alicia Michaelsen, BSN, RN, BMTCN®Multiple Myeloma | March 29, 2024
Alicia Michaelsen, BSN, RN, BMTCN, discusses the importance of raising awareness.
Cecilia BrownMultiple Myeloma | March 18, 2024
The withdrawal comes 2 years after the FDA granted accelerated approval to the treatment.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 18, 2024
Oncology nurses must be able to quickly identify hypercalcemia because it can cause cardiac arrest or coma.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 18, 2024
Hypercalcemia is the most common oncologic emergency, which makes it critical to understand this electrolyte imbalance.
Cecilia BrownMultiple Myeloma | March 12, 2024
A new study shows why it's critical to assess patients for financial and time toxicity.
Advertisement
Advertisement
Advertisement